Progressive flow-to-volume dysanapsis in cystic fibrosis: A predictor for lung transplantation?

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 1, 2012, Pages 82-87

  Vilozni, Daphna ^a   Lavie, Moran ^a   Sarouk, Ifat ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cystic fibrosis; Flow volume ratio; Longitudinal; Spirometry

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRONCHUS HYPERREACTIVITY; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SPIROMETRY;

ADOLESCENT; AIRWAY OBSTRUCTION; CHILD; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG TRANSPLANTATION; MALE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SPIROMETRY; YOUNG ADULT;

EID: 84863461821     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201202-0272OC     Document Type: Article

References (26)

1. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003;361:681-689. (Pubitemid 36246556)
2. Tiddens HA, Donaldson SH, Rosenfeld M, Paré PD. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively? Pediatr Pulmonol 2010;45:107-117.
3. Hogg JC, Macklem PT, Thurlbeck WM, Path MC. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278:1355-1360.
4. Jones MH, Howard J, Davis S, Kisling J, Tepper RS. Sensitivity of spirometric measurements to detect airway obstruction in infants. Am J Respir Crit Care Med 2003;167:1283-1286. (Pubitemid 36555103)
5. Davis S, Jones M, Kisling J, Howard J, Tepper RS. Comparison of normal infants and infants with cystic fibrosis using forced expiratory flows breathing air and heliox. Pediatr Pulmonol 2001;31:17-23. (Pubitemid 32154736)
6. Tiddens HA. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002;34:228-231. (Pubitemid 34971078)
7. Zapletal A, Desmond KJ, Demizio D, Coates AL. Lung recoil and the determination of airflow limitation in cystic fibrosis and asthma. Pediatr Pulmonol 1993;15:13-18.
8. Bar-Yishay E, Amirav I, Goldberg S. Comparison of maximal midexpiratory flow rate and forced expiratory flow at 50% of vital capacity in children. Chest 2003;123:731-735. (Pubitemid 36315485)
9. Martin TR, Feldman HA, Fredberg JJ, Castile RG, Mead J, Wohl ME. Relationship between maximal expiratory flows and lung volumes in growing humans. J Appl Physiol 1988;65:822-828.
10. Mead J. Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis 1980;121:339-342. (Pubitemid 10095228)
11. Litonjua AA, Sparrow D, Weiss ST. The FEF25-75/FVC ratio is associated with methacholine airway responsiveness. The Normative Aging study. Am J Respir Crit Care Med 1999;159:1574-1579. (Pubitemid 29227872)
12. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. ATS/ERS Task Force. Eur Respir J 2005;26:319-338. (Pubitemid 41079078)
13. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
14. Quanjer PH, Stocks J, Polgar G, Wise M, Karlberg J, Borsboom G. Compilation of reference values for lung function measurements in children. Eur Respir J Suppl 1989;4:184S-261S. (Pubitemid 19135696)
15. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coastes A, van der Grinten CPM, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung-function tests. Eur Respir J 2005;26:948-968.
16. Tiddens HAWM, Hofhuis W, Bogaard JM, Hop WCJ, de Bruin H, Willems LNA, de Jongste JC. Compliance, hysteresis, and collapsibility of human small airways. Am J Respir Crit Care Med 1999;160:1110-1118. (Pubitemid 29487447)
17. Hart N, Polkey MI, Clément A, Boulé M, Moxham J, Lofaso F, Fauroux B. Changes in pulmonary mechanics with increasing disease severity in children and young adults with cystic fibrosis. Am J Respir Crit Care Med 2002;166:61-66. (Pubitemid 34693964)
18. Konstan MW, Byard PJ, Hopel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis relatively insensitive to changes in small airways, especially in early disease. N Engl J Med 1995;332:848-854.
19. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS 2006;114:319-328. (Pubitemid 43829421)
20. Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, Aviram M, Rivlin J, Picard E, Lavy A, et al. Multicenter crosssectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 2008;14:378-384. (Pubitemid 351451383)
21. Walker NM, Simpson JE, Levitt RC, Boyle KT, Clarke LL. Talniflumate increases survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome. J Pharmacol Exp Ther 2006;317:275-283.
22. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, McKenzie SG, Navarro J, Strandvik B, Investigators of the European Epidemiologic Registry of Cystic Fibrosis. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001;32:343-350. (Pubitemid 33015650)
23. Eggleston PA, Rosenstein BJ, Stackhouse CM, Alexander MF. Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease. Chest 1988;94:360-365.
24. Thomas SR, Gyi KM, Gaya H, Hodson ME. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect 1998;40:203-209. (Pubitemid 28502304)
25. Doershuk CF, Stern RC. Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 1999;115:782-787.
26. Rosenbluth DB, Wilson K, Ferkol T, Schuster DP. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 2004;126:412-419. (Pubitemid 39093425)